151 related articles for article (PubMed ID: 27255379)
1. Statistical inference of a convergent antibody repertoire response to influenza vaccine.
Strauli NB; Hernandez RD
Genome Med; 2016 Jun; 8(1):60. PubMed ID: 27255379
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain.
Cortina-Ceballos B; Godoy-Lozano EE; Téllez-Sosa J; Ovilla-Muñoz M; Sámano-Sánchez H; Aguilar-Salgado A; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Aparicio-Antonio R; Rodríguez MH; Martínez-Barnetche J
Genome Med; 2015 Nov; 7():124. PubMed ID: 26608341
[TBL] [Abstract][Full Text] [Related]
3. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
6. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
7. Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controls.
Bickel M; Lassmann C; Wieters I; Doerr HW; Herrmann E; Wicker S; Brodt HR; Stephan C; Allwinn R; Jung O
HIV Clin Trials; 2013; 14(4):175-81. PubMed ID: 23924590
[TBL] [Abstract][Full Text] [Related]
8. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.
Andrews SF; Kaur K; Pauli NT; Huang M; Huang Y; Wilson PC
J Virol; 2015 Mar; 89(6):3308-17. PubMed ID: 25589639
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
[TBL] [Abstract][Full Text] [Related]
10. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial.
Uno S; Kimachi K; Kei J; Miyazaki K; Oohama A; Nishimura T; Ibaragi K; Odoh K; Kudo Y; Kino Y
Microbiol Immunol; 2011 Nov; 55(11):783-9. PubMed ID: 21895745
[TBL] [Abstract][Full Text] [Related]
11. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.
Gauger PC; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA; Vincent AL
Viral Immunol; 2013 Oct; 26(5):314-21. PubMed ID: 24033080
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
[TBL] [Abstract][Full Text] [Related]
14. A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged.
Kannan S; Kossenkov A; Kurupati RK; Xiang JZ; Doyle SA; Schmader KE; Schowe L; Ertl HC
Aging (Albany NY); 2015 Dec; 7(12):1077-85. PubMed ID: 26637961
[TBL] [Abstract][Full Text] [Related]
15. Possible Impact of Yearly Childhood Vaccination With Trivalent Inactivated Influenza Vaccine (TIV) on the Immune Response to the Pandemic Strain H1N1.
Amer A; Fischer H; Li X; Asmar B
Clin Pediatr (Phila); 2016 Mar; 55(3):245-50. PubMed ID: 26159622
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
[TBL] [Abstract][Full Text] [Related]
17. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I
Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D
J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age.
Vesikari T; Block SL; Guerra F; Lattanzi M; Holmes S; Izu A; Gaitatzis N; Hilbert AK; Groth N
Pediatr Infect Dis J; 2012 May; 31(5):494-500. PubMed ID: 22301476
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]